Lyme Disease Diagnostic Devices Market

Lyme disease diagnostic devices are used to detect disease which is caused by the spirochete Borrelia burgdorferi and transmitted by vector Ixodes scapular,

Lyme Disease Diagnostic Devices Market contains market size and forecasts of Lyme Disease Diagnostic Devices in global, including the following market information:

Global Lyme Disease Diagnostic Devices Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Lyme Disease Diagnostic Devices Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five Lyme Disease Diagnostic Devices companies in 2021 (%)

The global Lyme Disease Diagnostic Devices market was valued at 946.5 million in 2021 and is projected to reach US$ 1531.8 million by 2028, at a CAGR of 7.1% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Serological Test Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Lyme Disease Diagnostic Devices include Abbott Laboratories, T2 Biosystems, Inc., Bio-Rad Laboratories, Alere Inc., Roche Diagnostics, Covance Inc., Immunetics, Inc., GlaxoSmithKline plc(GlaxoSmithKline Pharmaceuticals Ltd) and Oxford Immunotec Global PLC(Boulder Diagnostics Inc.), etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Lyme Disease Diagnostic Devices manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Lyme Disease Diagnostic Devices Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Lyme Disease Diagnostic Devices Market Segment Percentages, by Type, 2021 (%)

Serological Test

Urine Antigen Tests

Lymphocytic Transformation Test

Immunofluorescent Staining

Nucleic Acid Test

Global Lyme Disease Diagnostic Devices Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Lyme Disease Diagnostic Devices Market Segment Percentages, by Application, 2021 (%)

Hospitals

Public/Private Laboratories

Physician?s Office

Global Lyme Disease Diagnostic Devices Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Lyme Disease Diagnostic Devices Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Lyme Disease Diagnostic Devices revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Lyme Disease Diagnostic Devices revenues share in global market, 2021 (%)

Key companies Lyme Disease Diagnostic Devices sales in global market, 2017-2022 (Estimated), (K Units)

Key companies Lyme Disease Diagnostic Devices sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Abbott Laboratories

T2 Biosystems, Inc.

Bio-Rad Laboratories

Alere Inc.

Roche Diagnostics

Covance Inc.

Immunetics, Inc.

GlaxoSmithKline plc(GlaxoSmithKline Pharmaceuticals Ltd)

Oxford Immunotec Global PLC(Boulder Diagnostics Inc.)

Thermo Fisher Scientific(Affymetrix)

Siemens AG

Baxter International Inc.

Fresenius Medical Care AG & Co.